Cover Image
Market Research Report
Product code 
1091873

United States Medical Enzymes Market Forecast 2022-2028

Published: | Inkwood Research | 145 Pages | Delivery time: 2-3 business days

Price

Back to Top
United States Medical Enzymes Market Forecast 2022-2028
Published: June 21, 2022
Inkwood Research
Content info: 145 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The United States medical enzymes market is evaluated to rise with a CAGR of 6.43% across the forecasted period. While the base year regarded for the studied market is 2021, the estimated years are from 2022 to 2028. The country's market growth is mainly ascribed to increasing consciousness about health and personal care, technological developments and innovations, and extensive research activities linked to medical enzymes.

MARKET INSIGHTS

Enzymes are characterized as biocatalysts with the potential to alter the rate of reaction. On the other hand, it also produces the desired results in biological reactions. Medical enzymes are primarily utilized to eliminate disease-causing microorganisms, diagnose certain diseases, and promote wound healing. Moreover, enzyme technology is further being employed for the treatment of major conditions, such as cancer, lysosomal ailments, and metabolic diseases.

The presence of top players operating in the United States plays a vital role in fueling the country's medical enzymes market. In this regard, the partnerships, collaborations, and product launches initiated by these companies are essential for the country's market growth, as well. For example, Nestle Health Science and Codexis partnered for the discovery of novel enzyme therapies. The collaboration primarily focused on the treatment of gastrointestinal disorders. Likewise, Codexis further extended its partnership with Tate and Lyle, a global supplier of food and beverage ingredients. As a result, these factors are anticipated to proliferate the medical enzymes market growth in the United States during the forecast years.

COMPETITIVE INSIGHTS

Key players operating in the market are: Novus, DSM, Thermo Fisher Scientific, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 46196

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
  • 3.2. KEY MARKET TRENDS
  • 3.3. PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1. BUYERS POWER
    • 3.3.2. SUPPLIERS POWER
    • 3.3.3. SUBSTITUTION
    • 3.3.4. NEW ENTRANTS
    • 3.3.5. INDUSTRY RIVALRY
  • 3.4. OPPORTUNITY MATRIX
  • 3.5. PESTLE ANALYSIS - UNITED STATES
  • 3.6. VALUE CHAIN ANALYSIS
    • 3.6.1. RESEARCH AND DEVELOPMENT
    • 3.6.2. OPERATIONS
    • 3.6.3. OUTBOUND LOGISTICS
  • 3.7. KEY BUYING CRITERIA
    • 3.7.1. COST
    • 3.7.2. QUALITY
    • 3.7.3. APPLICATION

4. MARKET BY TYPE

  • 4.1. HYDROLASE
    • 4.1.1. HYALURONIDASE
    • 4.1.2. LYSOZYMES
    • 4.1.3. OTHER HYDROLASES ENZYMES
  • 4.2. THROMBOLYTIC
    • 4.2.1. STREPTOKINASE
    • 4.2.2. UROKINASE
    • 4.2.3. OTHER THROMBOLYTIC ENZYMES
  • 4.3. DIGESTIVE ENZYME
    • 4.3.1. LACTASE
    • 4.3.2. L-ASPARAGINASE
    • 4.3.3. OTHER DIGESTIVE ENZYMES
  • 4.4. ENDONUCLEASE
    • 4.4.1. BENZONASE
    • 4.4.2. OTHER ENDONUCLEASES

5. MARKET BY APPLICATION

  • 5.1. DISEASE TREATMENT
  • 5.2. DIAGNOSTIC TOOLS
  • 5.3. BIOMEDICAL RESEARCH
  • 5.4. OTHER APPLICATIONS

6. COMPETITIVE LANDSCAPE

  • 6.1. KEY STRATEGIC DEVELOPMENTS
    • 6.1.1. MERGERS & ACQUISITIONS
    • 6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 6.1.3. PARTNERSHIPS & AGREEMENTS
    • 6.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 6.2. COMPANY PROFILES
    • 6.2.1. CODEXIS
    • 6.2.2. DSM
    • 6.2.3. DUPONT
    • 6.2.4. NOVOZYMES
    • 6.2.5. NOVUS
    • 6.2.6. THERMO FISHER SCIENTIFIC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES
  • TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES
  • TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY
  • TABLE 4: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 6: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 14: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 16: LIST OF MERGERS & ACQUISITIONS
  • TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: PESTLE ANALYSIS
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
  • FIGURE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
  • FIGURE 9: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
  • FIGURE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
  • FIGURE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
  • FIGURE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
  • FIGURE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)
  • FIGURE 14: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
  • FIGURE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
  • FIGURE 16: UNITED STATES MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
  • FIGURE 17: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)
  • FIGURE 18: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
  • FIGURE 19: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
  • FIGURE 20: UNITED STATES MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
  • FIGURE 21: UNITED STATES MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
  • FIGURE 22: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)
  • FIGURE 23: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
  • FIGURE 24: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
  • FIGURE 25: UNITED STATES MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
  • FIGURE 26: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)
  • FIGURE 27: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
  • FIGURE 28: UNITED STATES MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
  • FIGURE 29: UNITED STATES MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
  • FIGURE 30: UNITED STATES MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)
  • FIGURE 31: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)